Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Direct detection of malignant mutations in patients with hypertrophic cardiomyopathy].

Revista espanola de cardiologia - 1 Oct 2003

García-Castro Mónica, Reguero Julián R, Batalla Alberto, Catalán Felicitas, Mayordomo Juan, Coto Eliecer

Abstract excerpt

We determined the prevalence of mutations considered malignant in the genes for beta-myosin heavy chain (MYH7, 11 mutations) and troponin T (TNNT2, 5 mutations) in 30 patients with hypertrophic cardiomyopathy aged 18 to 60 years, 83% of whom had familial antecedents of hypertrophic myocardiopathy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Cardiomyopathy, Hypertrophic
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MYH7 gene

Share to TNNT2 gene

Share to Mutation

Source

Identifiers

PMID: 14563299
DOI: 10.1016/s0300-8932(03)77002-x

Genes

MYH7
TNNT2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-14563299-2026-09-02.1. Manifest publication-graph-cohort-2026-09-02.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Direct detection of malignant mutations in patients with hypertrophic cardiomyopathy].PMID 14563299Read ↗

Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.Semantic proximity Read ↗

Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.Semantic proximity Read ↗

[Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy].Semantic proximity Read ↗

Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients.Semantic proximity Read ↗

Mutations in the beta-myosin heavy chain gene in southern Chinese families with hypertrophic cardiomyopathy.Semantic proximity Read ↗

Sudden cardiac death in familial hypertrophic cardiomyopathy: are "benign" mutations really benign?Semantic proximity Read ↗

[Hypertrophic cardiomyopathy: from diagnosis to prevention].Semantic proximity Read ↗

[Hypertrophic cardiomyopathy: infrequent mutation of the cardiac beta-myosin heavy-chain gene].Semantic proximity Read ↗

Novel mitochondrial DNA mutations in a rare variety of hypertrophic cardiomyopathy.Semantic proximity Read ↗

A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophySemantic proximity Read ↗

[Mitochondrial DNA mutations in patients with myocardial diseases].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.